SPY AGENT GREEN KIT
Peakindocyanine green
NDAINTRAVENOUS, INTERSTITIALPOWDER
Approved
Nov 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
12
Data completeness
3/8 — Basic
Drug data last refreshed 3d ago
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (12)
The Value of Indocyanine Green-guided Near-infrared Fluorescence Technology in Tracing Sentinel Lymph Nodes During Esophagectomy
Started Jan 2026
144 enrolled
Esophageal CancerSentinel Lymph NodeLymphadenectomy+1 more
Real-Time Diagnosis of Life-Threatening Necrotizing Soft Tissue Infections (NSTI) Using Indocyanine Green (ICG) Kinetic Modeling
Started Sep 2025
420 enrolled
Necrotizing Fascitis
Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema
Started Aug 2025
Use Of Indocyanine Green In Pancreas Surgery
Started May 2024
55 enrolled
Pancreatic Carcinoma
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
Started Apr 2024
417 enrolled
Parathyroid DysfunctionAdenoma
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.